Company Profile
Wanbangde Pharmaceutical Holding develops, produces, and sells traditional Chinese medicine, chemical raw materials, and chemical preparations in China and globally. Its operations are structured into two segments, the Pharmaceutical Business and the Medical Device Business.
It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. It also develops and sells orthopedic implant devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc..
Its portfolio also includes medical equipment, disposable sterile medical polymer consumables, and hospital engineering services. Founded in 1985 and headquartered in Taizhou, China, Wanbangde Pharmaceutical was formerly known as Wanbangde New Building Materials Co., Ltd. before rebranding in April 2020.